Strategic Partnerships Dyno Therapeutics has established strategic partnerships with industry giants like NVIDIA, Sarepta, Novartis, and Roche, indicating a strong network and potential collaboration opportunities for sales development.
Innovative Product Launches The recent launch of Dyno eCap 1 capsid product and breakthrough Optimized AAV Capsids for eye and CNS Gene Delivery showcase the company's commitment to innovation, providing opportunities for sales representatives to promote cutting-edge solutions.
Award-Winning Recognition Recognized as the Emerging Company of the Year at the 2021 NEVY Awards, Dyno Therapeutics' accolades can be leveraged by sales professionals to build credibility and attract potential clients seeking industry-leading partners.
AI-Powered Drug Design Platform By leveraging the NVIDIA BioNeMo AI-powered drug design platform, Dyno Therapeutics is at the forefront of advanced technology, offering a competitive edge in the market and opening doors for sales opportunities in the tech-driven healthcare sector.
Industry Impact As a techbio company pioneering AI applications in genetic medicine, Dyno Therapeutics is well-positioned to drive industry trends and attract clients looking for groundbreaking solutions, presenting significant sales potential for forward-thinking sales reps.
51
$10M$50M
482$50M$100M
46$10M
26$10M
332$10M$50M
504$100M$1B
51$10M$50M
47$10M
27
105$10M$50MDyno Therapeutics uses 8 technology products and services including Google Analytics, LinkedIn Recruiter, jsDelivr, and more. Explore Dyno Therapeutics's tech stack below.
| Dyno Therapeutics Email Formats | Percentage |
| First.Last@dynotx.com | 98% |
| FL@dynotx.com | 1% |
| First@dynotx.com | 1% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Dyno Therapeutics is a VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.
Company Overview
Media & News
Funding & FinancialsDyno Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 06, 2021 in the amount of $100M.
Dyno Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsDyno Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 06, 2021 in the amount of $100M.
Dyno Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com